Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinct molecular subgroups in pediatric and young-onset meningiomas require age-adapted risk stratification.

Nature communications·2026
Same author

Amsterdam IMAging and Clinical GliOma Dataset; IMAGO.

Scientific data·2026
Same author

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes.

Nature cancer·2026
Same author

AOSNP-ADAPTR resource level-based recommendations on practical diagnostic strategies for ependymomas.

Brain pathology (Zurich, Switzerland)·2026
Same author

Primary Mismatch Repair Deficient Glioma (PMMRDG), IDH-wildtype and H3-wildtype: A Giant Cell Tumor with Potential for Long-Term Survival Occurring at all Ages.

Neuro-oncology·2026
Same author

cIMPACT-NOW update 12: Refining Pathology-based Risk Stratification and Grading for IDH-mutant Gliomas.

Neuro-oncology·2026

Related Experiment Video

Updated: Mar 9, 2026

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
10:13

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

14.0K

Glioma: experimental models and reality.

Krissie Lenting1, Roel Verhaak2, Mark Ter Laan3

  • 1Department of Pathology, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.

Acta Neuropathologica
|January 12, 2017
PubMed
Summary

Exploring glioma models is crucial for understanding brain tumor biology and developing new treatments. Current models must accurately reflect genetic and micro-environmental factors for reliable therapeutic validation.

More Related Videos

Translational Orthotopic Models of Glioblastoma Multiforme
07:37

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

3.9K
Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
10:58

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Published on: February 22, 2015

13.5K

Related Experiment Videos

Last Updated: Mar 9, 2026

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
10:13

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

14.0K
Translational Orthotopic Models of Glioblastoma Multiforme
07:37

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

3.9K
Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
10:58

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Published on: February 22, 2015

13.5K

Area of Science:

  • Neuro-oncology
  • Cancer Biology
  • Translational Research

Background:

  • Human gliomas possess complex genetic aberrations and unique brain micro-environments.
  • In vitro and in vivo models are essential for studying glioma biology and developing treatments.
  • Existing glioma models face challenges in accurately replicating these complexities.

Purpose of the Study:

  • To review current glioma models and their utility in research.
  • To assess the strengths and weaknesses of various models.
  • To highlight the importance of model fidelity for therapeutic development.

Main Methods:

  • Literature review of glioma models.
  • Analysis of genotypic, phenotypic, and metabolic characteristics.
  • Discussion of model limitations in predicting therapeutic outcomes.

Main Results:

  • Glioma models must meet stringent demands related to genetic and micro-environmental mimicry.
  • Inadequate models can lead to misleading results in therapy experiments.
  • Model selection is critical for reliable drug development and validation.

Conclusions:

  • Accurate glioma models are vital for advancing our understanding and treatment of brain tumors.
  • Future research should focus on developing and validating models that better recapitulate human glioma characteristics.
  • Careful consideration of model limitations is essential for successful therapeutic strategies.